feed,title,long_url,short_url
Benzinga,Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study,https://benzinga.com/general/biotech/22/08/28377189/akebias-anemia-drug-disappoints-in-mid-stage-covid-19-study,https://bit.ly/3P1TXHM
Benzinga,Palantir Looks To Ramp Up Headcount By 25%: Report,https://benzinga.com/news/22/08/28377651/palantir-looks-to-ramp-up-headcount-by-25-report,https://bit.ly/3d2bUZj
Benzinga,$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today,https://benzinga.com/news/earnings/22/08/28377550/1000-invested-in-vertex-pharmaceuticals-10-years-ago-would-be-worth-this-much-today,https://bit.ly/3p3uXVP
Benzinga,$100 Invested In Verisk Analytics 10 Years Ago Would Be Worth This Much Today,https://benzinga.com/news/earnings/22/08/28377547/100-invested-in-verisk-analytics-10-years-ago-would-be-worth-this-much-today,https://bit.ly/3d3r0Ol
